Overall, the data indicated that JWA negatively regulates DR4 expression via the ubiquitin-dependent lysosome pathway, which mediates the sensitivity of cisplatin-resistant GC cells to TRAIL. This evidence concerns the gene ARL6IP5 and gastric cancer.